Gregory Stewart

Gregory Stewart is a Senior Research Fellow at the Neuromedicines Discovery Centre (NDC) at Monash University, actively contributing to pharmacological research with a focus on G protein-coupled receptors and their role in neuropsychiatric disorders. His work spans drug discovery, molecular pharmacology, and central nervous system research, with significant contributions to understanding schizophrenia mechanisms and potential therapeutic targets.

His research interests center on G protein-coupled receptor pharmacology, particularly examining serotonin receptors, orphan receptors relevant to schizophrenia, and novel therapeutic approaches for substance use disorders and cognitive impairments. Stewart's work demonstrates a strong translational focus, bridging basic molecular mechanisms with potential clinical applications in neuropsychiatric conditions.

His publication record shows consistent scholarly output with recent high-impact articles in journals like British Journal of Pharmacology and Translational Psychiatry, focusing on molecular insights into receptor mechanisms and preclinical development of novel therapeutics. His work demonstrates increasing influence in the field, with several publications receiving substantial citations.

• FRM Postdoctoral Fellowship (2010)
• MedTech Actuator Menzies Fellowship (December 2021)
• Postgraduate Publication Award (2009)

Stewart serves as a peer reviewer for prominent organizations including the US Endocrine Society and ASPET, demonstrating his standing in the scientific community. His collaborative work spans multiple institutions and involves significant research projects funded by the Australian Research Council and industry partners like TGR BioSciences and Phrenix Therapeutics.